Free Psychic Medium Readings | Chat with Real Mediums Online – Special 2025 Announcement

San Francisco, CA, May 31, 2025 (GLOBE NEWSWIRE) — – In today's digital age, connecting with a psychic medium is easier and more accessible than ever. Whether you're seeking comfort after a loss, clarity on life's deeper questions, or simply curious about the spiritual world, psychic medium readings offer profound insight. Through psychic mediums chat […]

Free Psychic Medium Readings | Chat with Real Mediums Online – Special 2025 Announcement

Free Psychic Medium Readings | Chat with Real Mediums Online – Special 2025 Announcement Free psychic medium readings and chat with real psychic mediums online now available for those seeking comfort and closure – just launched for 2025 by The Psychic Experts GlobeNewswire May 31, 2025 San Francisco, CA, May 31, 2025 (GLOBE NEWSWIRE) —

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

mNEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at

RED CAT SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Red Cat Holdings, Inc. – RCAT

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Red Cat Holdings, Inc. (NasdaqCM: RCAT), if they purchased the Company's securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”).This action is pending in

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. – OGN

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the “Class Period”). This action is pending in

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. – IOVA

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 15, 2025 to file lead plaintiff applications in a securities class action lawsuit against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NasdaqGM: IOVA), if they purchased the Company's securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). This

COMPASS DIVERSIFIED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Compass Diversified Holdings – CODI

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Compass Diversified Holdings (NYSE: CODI), if they purchased the Company's securities between May 1, 2024 and May 7, 2025, inclusive (the “Class Period”). This action is pending in

NET POWER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power Inc. – NPWR

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR), if they purchased the Company's securities between June 9, 2023 and March 7, 2025, inclusive (the “Class Period”).

CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world’s first circular RNA drug being administrated in patients

Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline HM2002 received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) for ischemic heart disease on May 30, 2025. https://mma.prnewswire.com/media/2699112/Shanghai_CirCode_Biomed_Logo.jpg With the first patient administrated on September of 2024 in an

Harford Mutual Insurance Group Announces Board Changes Following Annual Meeting

Harford Mutual Insurance Group (HMIG) has announced changes to its Board of Directors. The changes were approved at the Annual Meeting of the Policyholders and are effective May 21, 2025. https://mma.prnewswire.com/media/2015019/HMIG_Logo.jpg John J. DeMartini, Sean M. Garber, and Teresa Q. McTague were reelected as board members. DeMartini and Garber became board members in 2023. McTague

Scroll to Top